Rizwana Nasera, Maslekar Namrata, Chatterjee Kaushik, Yao Yin, Agarwal Vipul, Nune Manasa
Manipal Institute of Regenerative Medicine (MIRM), Bengaluru, Manipal Academy of Higher Education (MAHE), Manipal 576104, Karnataka, India.
Cluster for Advanced Macromolecular Design (CAMD), School of Chemical Engineering, University of New South Wales, Sydney, New South Wales 2052, Australia.
ACS Appl Nano Mater. 2023 Sep 25;7(16):18177-18188. doi: 10.1021/acsanm.3c02962. eCollection 2024 Aug 23.
Three-dimensional (3D) bioprinting has made it possible to fabricate structures with intricate morphologies and architectures, which is considered difficult to do when using other conventional techniques like electrospinning. Although the 3D printing of thermoplastics has seen a huge boom in the past few years, it has been challenging to translate this technology to cell-based printing. A major limitation in bioprinting is the lack of inks that allow for the printing of 3D structures that meet the biological requirements of a specific organ or tissue. A bioink is a viscous polymer solution that cells are incorporated into before printing. Therefore, a bioink must have specific characteristics to ensure both good printability and biocompatibility. Despite the progress that has been made in bioprinting, achieving a balance between these two properties has been difficult. In this work, we developed a multimodal bioink that serves as both a cell carrier and a free radical scavenger for treating peripheral nerve injury. This bioink comprises poly(vinyl alcohol) (PVA) and cerium oxide nanoparticles (also called nanoceria (NC)) and was developed with a dual crosslinking method that utilizes citric acid and sodium hydroxide. By employing this dual crosslinking method, good printability of the bioink and shape fidelity of the bioprinted structure were achieved. Additionally, a cell viability study demonstrated that the cells remained compatible and viable even after they underwent the printing process. The combination of this PVA/NC bioink and the dual crosslinking method proved to be effective in enhancing printability and cell biocompatibility for extrusion-based bioprinting applications.
三维(3D)生物打印能够制造出具有复杂形态和结构的组织,而使用其他传统技术(如电纺丝)则难以做到这一点。尽管热塑性塑料的3D打印在过去几年中取得了巨大的发展,但将这项技术转化为基于细胞的打印一直具有挑战性。生物打印的一个主要限制是缺乏能够打印出满足特定器官或组织生物学要求的3D结构的墨水。生物墨水是一种粘性聚合物溶液,细胞在打印前被掺入其中。因此,生物墨水必须具有特定的特性,以确保良好的可打印性和生物相容性。尽管在生物打印方面已经取得了进展,但要在这两种特性之间取得平衡一直很困难。在这项工作中,我们开发了一种多模态生物墨水,它既可以作为细胞载体,又可以作为治疗周围神经损伤的自由基清除剂。这种生物墨水由聚乙烯醇(PVA)和氧化铈纳米颗粒(也称为纳米铈(NC))组成,并采用了利用柠檬酸和氢氧化钠的双重交联方法开发而成。通过采用这种双重交联方法,实现了生物墨水良好的可打印性和生物打印结构的形状保真度。此外,细胞活力研究表明,即使在经历打印过程后,细胞仍保持相容性和活力。事实证明,这种PVA/NC生物墨水与双重交联方法的组合在增强基于挤出的生物打印应用的可打印性和细胞生物相容性方面是有效的。